Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – A prospective, randomized, controlled trial

Nicola Benjamin (Heidelberg, Germany), Nicola Benjamin, Hans Klose, Mona Lichtblauf, Johannes Weidenhammer, Christine Fischer, Robert Nechwatal, Sören Uiker, Michael Halank, Karen Olsson, Werner Seeger, Henning Gall, Stephan Rosenkranz, Heinrike Wilkens, Dirk Mertens, Hans-Jürgen Seyfarth, Christian Opitz, Silvia Ulrich, Benjamin Egenlauf, Ekkehard Grünig

Source: International Congress 2016 – Best abstracts in pulmonary rehabilitation and chronic care
Session: Best abstracts in pulmonary rehabilitation and chronic care
Session type: Oral Presentation
Number: 267
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Nicola Benjamin (Heidelberg, Germany), Nicola Benjamin, Hans Klose, Mona Lichtblauf, Johannes Weidenhammer, Christine Fischer, Robert Nechwatal, Sören Uiker, Michael Halank, Karen Olsson, Werner Seeger, Henning Gall, Stephan Rosenkranz, Heinrike Wilkens, Dirk Mertens, Hans-Jürgen Seyfarth, Christian Opitz, Silvia Ulrich, Benjamin Egenlauf, Ekkehard Grünig. Exercise training improves peak oxygen consumption and hemodynamics in patients with pulmonary hypertension – A prospective, randomized, controlled trial. Eur Respir J 2016; 48: Suppl. 60, 267

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Randomized, controlled, prospective multicenter study: Training improves peak oxygen consumption and hemodynamics in patients with chronic severe pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: improving treatment in PAH
Year: 2014


Effect of nocturnal oxygen and acetazolamide on exercise performance in patients with precapillary pulmonary hypertension and sleep disturbed breathing. Randomized, double-blind, cross-over trial
Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Year: 2013


Maintaining benefits following pulmonary rehabilitation: a randomised controlled trial
Source: Eur Respir J 2010; 35: 571-577
Year: 2010



Hyperoxia enhances exercise performance in PAH and CTEPH: Randomized trial
Source: International Congress 2016 – Clinic of pulmonary hypertension
Year: 2016

Effect of long-term oxygen therapy on exercise capacity and quality of life in exercise-desaturating patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension: a randomized-sham-controlled cross-over trial
Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension
Year: 2017

Effects of a 3-week pulmonary rehabilitation program in patients with idiopathic pulmonary fibrosis – A randomized, controlled trial
Source: International Congress 2016 – Novel approaches for pulmonary rehabilitation in chronic lung diseases
Year: 2016


Effect of macitentan on haemodynamics in SERAPHIN, a randomised controlled trial in pulmonary arterial hypertension (PAH)
Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Year: 2013


An open label study of ambrisentan in patients with exercise induced pulmonary arterial hypertension (EiPAH)
Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Year: 2013


Effect of macitentan on morbidity and mortality in pulmonary arterial hypertension: A randomised controlled trial (SERAPHIN)
Source: Annual Congress 2013 –Pulmonary circulation: treatment
Year: 2013

Short-burst oxygen therapy for COPD patients: a 6-month randomised, controlled study
Source: Eur Respir J 2006; 27: 697-704
Year: 2006



Open label study of ambrisentan in patients with exercise induced pulmonary arterial hypertension (EiPAH)
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016


Acute improvement of pulmonary hemodynamics does not alleviate Cheyne-Stokes respiration in chronic heart failure - a randomized, controlled, double-blind, crossover trial
Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing
Year: 2013

Standardised exercise training is feasible, safe and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension - results from a large European multicentre randomised controlled trial
Source: Virtual Congress 2020 – Updated assessment and treatment of pulmonary arterial hypertension
Year: 2020




Dexamethasone reduces pulmonary artery pressure in lowlanders with COPD travelling to 3200m. A randomized, placebo-controlled trial
Source: International Congress 2016 – Pulmonary hypertension: the clinic I
Year: 2016

Randomised controlled, crossover trial to evaluate the effects of ambulatory oxygen on health status in patients with fibrotic lung disease
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Inspiratory muscle training for patients with chronic obstructive pulmonary disease (IMTCO study): A multicentre randomised controlled trial
Source: International Congress 2016 – Best abstracts on the role of exercise and physical activity in chronic respiratory disease
Year: 2016


Does sildenafil improves exercise capacity and pulmonary artery hypertension in chronic obstructive pulmonary disease? A controlled trial
Source: Annual Congress 2009 - Pulmonary vascular diseases
Year: 2009


Home oxygen saturation monitoring and quality of life in patients with idiopathic pulmonary fibrosis: A prospective multicenter trial
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013

Effects of additional manual therapy over inspiratory muscle training in patients with chronic obstructive pulmonary disease: A randomized controlled trial
Source: International Congress 2015 – Latest insights in pulmonary rehabilitation and functional capacity
Year: 2015


Riociguat improves excessive exercise ventilation in patients with inoperable chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Year: 2013